# Epinephrine as a potential driver of oral lichen planus pathogenesis

**Authors:** Yu Gyung Kim, Kun-Hwa Kang, Hyo-Jin Song, Won Jung, Sungil Jang, Jin-Seok Byun, Do-Yeon Kim

PMC · DOI: 10.1080/19768354.2025.2588914 · Animal Cells and Systems · 2025-11-17

## TL;DR

Stress-related epinephrine may worsen oral lichen planus by causing cell damage and inflammation.

## Contribution

This study identifies epinephrine as a novel driver of oral lichen planus through oxidative stress and immune activation.

## Key findings

- High epinephrine levels cause cytotoxicity in oral keratinocytes and DNA damage.
- Epinephrine reduces antioxidant proteins SOD2 and SESN2, increasing oxidative stress.
- Epinephrine activates STAT3 signaling and increases DAMPs like HMGB1 and ATP.

## Abstract

Oral lichen planus (OLP) is a chronic inflammatory condition characterized by CD8+ T cell-mediated apoptosis of oral epithelial cells. While psychological stress has been implicated in OLP pathogenesis, the underlying mechanisms remain unclear. This study explores the role of epinephrine, a primary stress-related catecholamine, in OLP progression. We found that high concentrations of epinephrine induce cytotoxicity in oral keratinocytes, marked by reduced cell viability and increased DNA damage. High-dose epinephrine also elevates oxidative stress by downregulating antioxidant proteins SOD2 and SESN2. Additionally, it activates the STAT3 signaling pathway through both alpha- and beta-adrenergic receptors. Furthermore, epinephrine increases levels of HMGB1 and extracellular ATP, key damage-associated molecular patterns (DAMPs) that could perpetuate chronic inflammation in OLP. These findings suggest that stress-induced epinephrine may exacerbate OLP by promoting oxidative stress, epithelial damage, and immune activation. Given the increased vascularization in OLP lesions, epinephrine’s effects may be amplified in affected tissues. Understanding the link between stress and OLP pathogenesis could provide new therapeutic targets for managing this condition.

## Linked entities

- **Genes:** SOD2 (superoxide dismutase 2) [NCBI Gene 6648], SESN2 (sestrin 2) [NCBI Gene 83667], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], HMGB1 (high mobility group box 1) [NCBI Gene 3146]
- **Proteins:** SOD2 (superoxide dismutase 2), SESN2 (sestrin 2), STAT3 (signal transducer and activator of transcription 3), HMGB1 (high mobility group box 1)
- **Chemicals:** epinephrine (PubChem CID 838)
- **Diseases:** oral lichen planus (MONDO:0043923)

## Full-text entities

- **Genes:** SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, SESN2 (sestrin 2) [NCBI Gene 83667] {aka HI95, SES2, SEST2}
- **Diseases:** OLP (MESH:D017676), chronic (MESH:D002908), cytotoxicity (MESH:D064420), inflammation (MESH:D007249)
- **Chemicals:** catecholamine (MESH:D002395), ATP (MESH:D000255), Epinephrine (MESH:D004837)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12624973/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12624973/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12624973/full.md

---
Source: https://tomesphere.com/paper/PMC12624973